Not everyone can tolerate statins to reduce their high cholesterol, but now a new study finds the medication bempedoic acid (Nexletol) reduced the combined rate of bad cardiovascular events by 13%. “We’re very pleased with the results,” said study chair Dr. Steven Nissen, chief academic officer of the Heart, Vascular & Thoracic Institute at Cleveland… read on > read on >



















